[Review in geriatric medicine 2011]

Rev Med Suisse. 2012 Jan 11;8(323):23-7.
[Article in French]

Abstract

In 2011, new tools to evaluate life expectancy are available. Controversy about PSA-based screening for prostate cancer is still going on, with new data from the US Preventive services task force. A brief behavioral treatment for insomnia can be efficient and durable. Gliptines are be useful to avoid treatment-induced hypoglycemia in diabetic patients. New Alzheimer diagnostic criteria, including biomarkers, have been published.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Aging*
  • Alzheimer Disease* / diagnosis
  • Behavior Therapy
  • Biomarkers, Tumor / blood
  • Diabetes Mellitus, Type 2* / drug therapy
  • Dipeptidyl-Peptidase IV Inhibitors / administration & dosage
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects
  • Early Detection of Cancer
  • Geriatrics / trends
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects
  • Life Expectancy*
  • Male
  • Mass Screening
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms* / blood
  • Prostatic Neoplasms* / diagnosis
  • Prostatic Neoplasms* / prevention & control
  • Psychotherapy, Brief
  • Randomized Controlled Trials as Topic
  • Sleep Initiation and Maintenance Disorders* / therapy

Substances

  • Biomarkers, Tumor
  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Prostate-Specific Antigen